Who founded LAVA Therapeutics?

LAVA Therapeutics was founded by Ton Adang, Hans van der Vliet in 2016.

Who are LAVA Therapeutics's investors?

LAVA Therapeutics's investors include MRL Ventures Fund, Sanofi Ventures, Ysios Capital, Gilde Healthcare, Novo Holdings, REDMILE.

LAVA Therapeutics

Founded 2016 · 7 employees on LinkedIn · 8 known investors

Find your way into LAVA Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the LAVA Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.

AI & Machine Learning Biotech Healthtech Medical Devices

Founders & leadership

LAVA Therapeutics was founded in 2016 by Ton Adang and Hans van der Vliet.

Ton AdangFounder

Hans van der VlietHead of Innovation

Steve HurlyChief Executive Officer

Oxana PolyakovaChief Scientific Officer

Investors · 8

MRL Ventures Fundlisted by MRL Ventures FundCambridge · $25M

How we know: MRL Ventures Fund's portfolio page · lavatherapeutics.com · Not right? Tell us

Sanofi Ventureslisted by Sanofi VenturesCambridge · $5M

How we know: Sanofi Ventures's portfolio page · a partner's Signal profile · lavatherapeutics.com · the VCSheet dataset · Not right? Tell us

Ysios Capitallisted by Ysios CapitalBarcelona · $5.4M – $21.6M

How we know: Ysios Capital's portfolio page · a partner's Signal profile · funding news · lavatherapeutics.com · the VCSheet dataset · Not right? Tell us

Gilde HealthcarereportedUtrecht · $1.1M – $55M

How we know: lavatherapeutics.com · Not right? Tell us

Novo HoldingsreportedCopenhagen · $1.1M – $54M

How we know: a partner's Signal profile · Not right? Tell us

REDMILEreportedSan Francisco

How we know: lavatherapeutics.com · Not right? Tell us

Also in the syndicate · 2

BB Pureos BioventuresVersant

Funding

SEC filings, press & company announcements

Undisclosed amountSeries CSep 2020
Novo Ventures (lead), Sanofi Ventures (lead), BB Pureos Bioventures, Gilde Healthcare, MRL Ventures Fund, LLC, Redmile Group, LLC, Versant, Ysios Capital
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs - Lava Therapeuticslavatherapeutics.com · Sep 2020

Frequently asked questions

What does LAVA Therapeutics do?: LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.
Who founded LAVA Therapeutics?: LAVA Therapeutics was founded by Ton Adang, Hans van der Vliet in 2016.
Who are LAVA Therapeutics's investors?: LAVA Therapeutics's investors include MRL Ventures Fund, Sanofi Ventures, Ysios Capital, Gilde Healthcare, Novo Holdings, REDMILE.